Abstract
Objectives
We aimed to identify clinical, anamnestic, and sociodemographic characteristics associated with a positive swab for SARS-CoV2, and to provide a predictive score to identify at risk population in children aged 2–14 years attending school and tested for clinical symptoms of COVID-19.
Design
Cross sectional study.
Setting
Outpatient clinic of the IRCCS Burlo Garofolo, a maternal and child health tertiary care hospital and research centre in Italy.
Data collection and analysis
Data were collected through a predefined form, filled out by parents, and gathered information on sociodemographic characteristics, and specific symptoms, which were analysed to determine their association with a positive SARS-CoV-2 swab. The regression coefficients of the variables included in the multivariate analysis were further used in the calculation of a predictive score of the positive or negative test.
Results
Between September 20th and December 23rd 2020, from 1484 children included in the study, 127 (8.6%) tested positive. In the multivariate analysis, the variables retained by the model were the presence of contact with a cohabiting, non-cohabiting or unspecified symptomatic case (respectively OR 37.2, 95% CI 20.1–68.7; 5.1, 95% CI 2.7–9.6; 15.6, 95% CI 7.3–33.2); female sex (OR 1.49, 95% CI 1.0–2.3); age (6–10 years old: OR 3.2, 95% CI 1.7–6.1 p<0.001; >10 years old: OR 4.8, 95% CI 2.7–8.8 p<0.001); fever (OR 3.9, 95% CI 2.3–6.4); chills (OR 1.9, 95% CI 1.1–3.3); headache (OR 1.45, 95% CI 0.9–2.4); ageusia (OR 1.3, 95% CI 0.5–4.0); sore throat (OR 0.48, 95% CI 0.3–0.8); earache (OR 0.4, 95% CI 0.1–1.3); rhinorrhoea (OR 0.8, 95% CI 0.5–1.3); and diarrhoea (OR 0.52, 95% CI 0.2–1.1). The predictive score based on these variables generated 93% sensitivity and 99% negative predictive value.
Conclusions
The timely identification of SARS-CoV2 cases among children is useful to reduce the dissemination of the disease and its related burden. The predictive score may be adopted in a public health perspective to rapidly identify at risk children.
Publisher
Public Library of Science (PLoS)
Reference26 articles.
1. Epidemiological features of coronavirus disease 2019 in children: a meta-analysis;JG Wang;Eur Rev Med Pharmacol Sci,2021
2. COVID-19 infection in children: A systematic review and meta-analysis of clinical features and laboratory findings;M Mansourian;Arch Pediatr,2021
3. Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis;S Badal;J Clin Virol,2021
4. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease;Cochrane COVID-19 Diagnostic Test Accuracy Group;Cochrane Database Syst Rev,2021
5. Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta;JA King;CMAJ,2021